ACA

NEUTRALM&A

Arcosa, Inc.

2026-08-04

Price

$145.22

-0.07%

This is the 2026-08-04 snapshot — the signals and analysis for ACA as of this single trading day.

View full ACA research hub →

Score10.5Top Tier

Signals5/8 DNA0/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume1.1xvs 20d avg

Analysis

Arcosa's (ACA) price action is entirely dictated by its pending all-cash acquisition by CRH at $150 per share. The stock's exceptionally low realized volatility (3.0%) and strong trend signals (PERFECT_STACK, STEADY_CLIMB) reflect classic merger arbitrage behavior as shares consolidate tightly just below the buyout price. Furthermore, the current RISK_ON macro regime, characterized by virtually zero credit stress and ultra-tight High Yield spreads (0.78%), provides immense confidence in deal financing and completion, making this a high-conviction structural price discovery event.

Fired Signals

ALPHA MALESTEADY CLIMBGOLDEN CROSSBOLLINGER SQUEEZEPERFECT STACK

Key Takeaways

Actionable Thesis: ACA is trading as a pure merger arbitrage play at $145.22, offering a relatively low-risk ~3.3% spread to the $150/share all-cash acquisition price.
Key Risk: Regulatory hurdles or a rejection at the upcoming shareholder vote are the primary risks, though standard M&A class action investigations are already underway.
What to Watch: Focus shifts entirely away from fundamentals to deal execution, with Q2 earnings acting as a procedural event ahead of the September shareholder vote.

← Back to 2026-08-04 View Full ACA History →Yahoo Finance &nearr;